Could vitamin d predict cervical cancer treatment success?
NCT ID NCT07743918
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This study looks at whether vitamin D levels in the blood and cervical fluid before treatment can predict how well chemoradiotherapy works for locally advanced cervical cancer. Researchers will measure vitamin D in 100 women undergoing standard treatment and track their response and side effects. The goal is to see if vitamin D could serve as a biomarker to guide treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Pretreatment vitamin D assessment in serum and cervical lavage fluid
- What this could lead to
- If vitamin D levels predict treatment response, this could lead to a simple test to guide therapy and improve outcomes for cervical cancer patients.
- What could go wrong
- This is an observational study, so it cannot prove cause and effect. Results may not apply to all patients, and vitamin D levels could be influenced by many factors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Clinical Center Kragujevac
RECRUITINGKragujevac, Šumadija, 34000, Serbia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a triple-threat approach wipe out cervical cancer before surgery?
- Particle beam and immune therapy join forces against cervical cancer
- Dual immunotherapy plus chemo may shrink cervical tumors before surgery
- Protein clues may predict cervical cancer return
- Could a 3-Week radiation course beat the standard 5-Week for cervical cancer?
- New drug combo shows promise against advanced cervical cancer in early trial